Menu Search
Equities

Dingdang Health Technology Group Ltd

9886:HKG.HS

Dingdang Health Technology Group Ltd

Actions
  • Price (HKD)0.590
  • Today's Change0.01 / 1.72%
  • Shares traded2.30m
  • 1 Year change-72.43%
  • Beta--
Data delayed at least 15 minutes, as of Nov 06 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Dingdang Health Technology Group Ltd is a China based company mainly engaged in the business of pharmaceutical retail and medical consultation. The Company operates two segments. The Pharmaceutical and Healthcare Business segment is engaged in online direct sales, business distribution, offline smart pharmacies, express delivery services, and online medical consultation. The Others segment provides marketing services, marketplace services and other services. The Company mainly conducts businesses within the domestic market.

  • Revenue in HKD (TTM)5.34bn
  • Net income in HKD-216.46m
  • Incorporated2014
  • Employees2.51k
  • Location
    Dingdang Health Technology Group LtdDengshikou StreetDongcheng District, Building 1, Yard 50BEIJING ChinaCHN
  • Websitehttps://www.ddjkjt.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.